SAN DIEGO, CA--(Marketwired - October 20, 2016) - Medical Marijuana, Inc. (OTC PINK: MJNA) announced today that its portfolio company HempMeds® Mexico, the first and only company dedicated to the cannabis industry with approval from COFEPRIS to legally import one of its products, will be present at the Senate of Mexico's historic exhibition "Hemp for All," being held from Oct. 24-28 on the second floor terrace of the commissions tower in the Senate.
HempMeds® Mexico's hemp oil Real Scientific Hemp Oil-X™ (RSHO-X™) is the only product that has been legally imported to Mexico and that according to recent studies has demonstrated effectiveness in treating refractory epilepsy in Mexican patients.
"We are excited about the opportunity that the Mexican Senate is taking to learn more about cannabis and are optimistic that lawmakers in Mexico will continue working together to put together a complete marijuana reform bill that will benefit their citizens and continue their country's compassionate position on health," said Chief Executive Officer of Medical Marijuana, Inc. Dr. Stuart Titus.
The exhibition will be held in an open space where medicinal cannabis advocates will be able to share information on the many therapeutic benefits of medical marijuana to both Mexican lawmakers and the media. In addition, the event will feature a museum and exhibition area where different organizations and actors in favor of legalizing cannabis will be able to explain, first hand, the development of its products and the potential the industry has in Mexico, a country of over 120 million residents.
About HempMeds® Mexico
HempMeds® Mexico is a Mexico-based company that made history by being the first company to receive a COFEPRIS federal government import permit for the cannabis product RSHO-X™ for a medical indication. HempMeds® Mexico plans to work directly with the Mexican government to safely and legally provide access to CBD hemp oil products. For more information, please review the company's website at: http://www.hempmeds.mx.
About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.'s video statement, click here. Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.